Limited Competition: Institutional Development Award (IDeA) for Clinical & Translational Research (CTR) (P30 - CT Optional)

The summary for the Limited Competition: Institutional Development Award (IDeA) for Clinical & Translational Research (CTR) (P30 - CT Optional) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Limited Competition: Institutional Development Award (IDeA) for Clinical & Translational Research (CTR) (P30 - CT Optional): The Institutional Development Award (IDeA) program develops biomedical research capacity in states that have historically received low levels of NIH funding (IDeA states). The IDeA Clinical & Translational Research (CTR) program supports two programmatic tracks to build clinical and translational (C&T) research capacity to enable research on diseases and health challenges prevalent in IDeA states. IDeA CTR Development (CTR-D) awards focus on C&T research workforce development and infrastructure enhancement at health research organizations with limited clinical research capacity in IDeA states. IDeA CTR Network (CTR-N) awards support statewide (or multi-state) networks of health research organizations to expand existing infrastructure, develop the research workforce to enhance the network organization's ability to design and implement competitive C&T research programs, and coordinate clinical research activities state-wide and/or across IDeA states.This is a Notice of Funding Opportunity (NOFO) for a Limited Competition that will invite application(s) from eligible organization(s) to apply. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered.

Federal Grant Title:	Limited Competition: Institutional Development Award (IDeA) for Clinical & Translational Research (CTR) (P30 - CT Optional)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAR-27-056
Type of Funding:	Grant
CFDA Numbers:	93.859
CFDA Descriptions:	Information not provided
Current Application Deadline:	May 30th, 2029
Original Application Deadline:	May 30th, 2029
Posted Date:	August 19th, 2026
Creation Date:	August 19th, 2026
Archive Date:	July 30th, 2029
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	August 19th, 2026

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility: Eligibility Criteria for Lead and Partner OrganizationsEvery organization in the application must be either a Lead or a Partner–no organization can be both.Every organization in the application must be in an IDeA-eligible state.There are strict limits to avoid overlap:Each IDeA-eligible state can only have one active IDeA-CTR-type (IDeA-CTR, CTR-N, or CTR-D) award at a time.An organization can only be involved in one IDeA-CTR-type award at a time.Organizations may not serve as a lead, partner or otherwise participate with an active Clinical and Translational Science Award (CTSA). Organizations must meet all eligibility rules at the time of application submission and award.Additional Eligibility Criteria for Lead OrganizationsTo apply as the lead, the organization must:Already have externally-funded clinical and translational (C&T) research.Additional Eligibility Criteria for Partner OrganizationsTo participate as a partner, the organization mustBe in the same state or multi-state region as the lead organization.Note:Active awards include awards in no-cost extension (NCE).An organization that currently leads an active IDeA-CTR-type award may submit a new application if substantial changes to the CTR are proposed. If the new application is funded, the current award will be administratively ended before the new award begins.
Grant Announcement Contact: NIGMS IDeA CTR
[email protected]
[email protected]
Similar Government Grants: • Limited Competition: NIGMS Mature Synchrotron Resources (MSR) for Structural Biology (P30 ...; • Limited Competition: Centers of Biomedical Research Excellence: Development Phase (COBRE-D...; • Limited Competition: Centers of Biomedical Research Excellence: Expansion/Sustainability P...; • Biomedical Technology Optimization and Dissemination Center (BTOD) (RM1 - Clinical Trial N...; • Maximizing Investigators' Research Award (MIRA) for Early Stage Investigators (ESI); • Tools for Genetic and Genomic Studies in Emerging Model Organisms; • Evolution of Infectious Diseases; • Mbrs Support of Continuous Research Excellence (Score)
More Grants from the National Institutes of Health: • Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiologi...; • Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required); • Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Not ...; • Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required); • Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P5...